Skip to content
Clinical Trials – home
Applied Therapeutics Inc.
Sponsor

Applied Therapeutics Inc.

United States 545 5th Avenue, 10017-3609, United States

About the sponsor

Applied Therapeutics Inc. is focused on Sorbitol Dehydrogenase (SORD) Deficiency, a rare inherited condition affecting carbohydrate metabolism and neuromuscular function. Its clinical research in this area centers on disease-specific therapeutic development for patients with unmet medical need.

  • Sorbitol Dehydrogenase (SORD) Deficiency
  • Inherited metabolic disease
  • Rare disease therapy

The sponsor’s clinical activity reflects interest in conditions where metabolic dysfunction is linked to progressive functional impairment.

About Specializations

Applied Therapeutics Inc. runs clinical trials in conditions such as Neuropathy peripheral, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neuropathy peripheral

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:GOVORESTAT
  • Sponsor:Applied Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.